2026年11月7日 9:50 ET 发布 · 更新于 7 天前 · 3 个来源
Novartis Abandons Heart Drug After Surprising Failure in Key Study
bloomberg
·
原始报道
INFERY
Novartis AG is largely abandoning an experimental drug analysts once considered a potential blockbuster after a study found it had little promise for preventing heart attacks and cardiovascular deaths.
原文